Enhanced Coordinated Specialty Care for Early Psychosis

Recruiting N/A Interventional Study
Psychosis Schizophrenia Schizoaffective Disorder Psychosis Nos/Other Bipolar Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
350 (estimated)
Sponsor
Mclean Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is: • Does the addition of certain elements of care increase the number of visits in treatment for first-episode psychosis? Participants will either: * Receive care as usual (CSC) or * Rece…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * People undergoing an intake evaluation to CSC for first-episode psychosis in one of the following outpatient clinics: * McLean Hospital OnTrack (OnTrack Clinic) * Massachusetts General Hospital (FEPP Clinic) * Boston Medical Center (WRAP Clinic) * Cambridge Health Alliance (RI…
Contacts

Dost Ongur, MD, PhD

617-855-3922

dongur@mgb.org

CONTACT

Jacqueline Dow, MPH

617-855-3321

jdow@mclean.harvard.edu

CONTACT